Streetbeat News

Products Services

ANNX

Annexon shares are trading higher after the company announced positive results from the Phase 3 trial of its C1q-targeted immunotherapy, ANX005, in Guillain-Barré Syndrome at the 2024 Peripheral Nerve Society Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:47 am

SVRA

Savara shares are trading higher following the announcement of positive results from the pivotal, Phase 3 IMPALA-2 clinical trial.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:42 am

APYX

Apyx Medical Corporation (NASDAQ:APYX) has launched the 'Renewing Lives' campaign, offering free Renuvion treatments to those in need. Renuvion is an FDA-cleared body contouring technology that targets loose skin, potentially improving physical, mental, and emotional health. For every Renuvion procedure performed in the U.S., Apyx Medical will donate to the campaign to fund treatments for those who need it most.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:39 am

LILM

Lilium N.V. (NASDAQ:LILM) has successfully completed the first series of tests of its electric jet propulsion unit, achieving maximum thrust and demonstrating expected performance and reliability. This marks a significant step towards zero-emission flight and the safety verification of the Lilium Jet.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:35 am

ENVX

Enovix Corporation (NASDAQ:ENVX) has signed a Memorandum of Understanding (MOU) with Elentec Co., Ltd to enhance global battery pack manufacturing. This agreement aims to establish a long-term business relationship, leveraging Elentec's design and manufacturing capabilities to support Enovix's growth.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:33 am

EVAX

Evaxion has announced that an international preliminary report on patentability for its AI-based novel cancer vaccine target identification method indicates promising prospects for obtaining granted patents and protecting the invention.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:32 am

BTCUSD

Julian Assange, founder of WikiLeaks, is set to return to Australia after a long legal battle with the U.S. government. WikiLeaks turned to Bitcoin for financial support after being cut off by PayPal, Visa, and MasterCard. Bitcoin donations have significantly appreciated in value over the years.

Portfolio Pulse from Aniket Verma

June 26, 2024 | 11:21 am

LYEL

Lyell Immunopharma announced promising initial clinical and translational data from its Phase 1 trial of LYL797, a reprogrammed ROR1 CAR T-cell product for blood cancers. The trial showed dose-dependent antitumor activity in ROR1+ relapsed/refractory triple-negative breast cancer, with a 40% objective response rate and 60% clinical benefit rate at the highest dose. No significant safety issues were observed, and development is expanding into new tumor types. An IND submission for LYL119, a next-generation ROR1-targeted CAR T cell product, has been completed.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:10 am

NAK

Northern Dynasty Minerals Ltd. (NYSE:NAK) reports that two Alaska Native Village corporations, Iliamna Natives Limited and Alaska Peninsula Corporation, have filed a lawsuit against the EPA for vetoing the Pebble Project. The lawsuit claims the EPA exceeded its authority and ignored the potential economic benefits for local communities.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:08 am

TD

TD Bank has announced a collaboration with MPower Financing to simplify the banking experience for international students in Canada. This partnership aims to provide easier access to financial services for students studying abroad.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 11:05 am